Hua Medicine (Shanghai) Ltd. (OTCMKTS:HUMDF) Short Interest Down 99.8% in October

Hua Medicine (Shanghai) Ltd. (OTCMKTS:HUMDF) saw a large decrease in short interest during the month of October. As of October 15th, there was short interest totalling 400 shares, a decrease of 99.8% from the September 30th total of 175,900 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Hua Medicine (Shanghai) Price Performance

OTCMKTS:HUMDF remained flat at C$0.15 during trading hours on Friday. Hua Medicine has a one year low of C$0.15 and a one year high of C$0.15. The company’s 50 day moving average is C$0.18 and its two-hundred day moving average is C$0.20.

About Hua Medicine (Shanghai)

Hua Medicine (Shanghai) Ltd. operates as a drug development company that focuses on therapies for the treatment of diabetes in China. It develops Dorzagliatin or HMS5552, an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin for treatment of T2D.